Table 2. Radiological findings, operative strategy and pathological results of MC.

Variable	Value (n=47)
Pathological mean diameter in mm [range]	28±20 [10–100]
Solid or part-solid GGO	40 (85.1%)
First surgical procedure
Lobectomy	26 (55.3%)
Segmentectomy	10 (21.3%)
Wedge resection	2 (4.3%)
Combination	9 (19.1%)
Lobectomy + wedge	5 (10.6%)
Double segmentectomy	1 (2.1%)
Wedge resections	3 (6.4%)
Final pathology
Acinar ADC	25 (53.3%)
Papillary ADC	5 (10.6%)
Solid ADC	4 (8.5%)
Mucinous ADC	1 (2.1%)
ADC NOS	3 (6.4%)
Acinar + papillary ADC	1 (2.1%)
Lepidic + acinar ADC	1 (2.1%)
Lepidic ADC	3 (6.4%)
MIA	2 (4.2%)
AIS	1 (2.1%)
ADC + neuroendocrine	1 (2.1%)
Pathologic stage
IA	26 (55.3%)
IB	11 (23.4%)
IIA	2 (4.3%)
IIB	4 (8.5%)
IIIA	4 (8.5%)
Lymph node metastasis
Hilar	3 (6.3%)
Mediastinal	2 (4.3%)
Patients with all lesions resected	9 (19.1%)

MC, main cancer; GGO, ground-glass opacity; ADC, adenocarcinoma; MIA, minimally invasive adenocarcinoma; AIS, adenocarcinoma in situ.